ALNOV.PA
Novacyt SA
Price:  
0.51 
EUR
Volume:  
50,262.00
France | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALNOV.PA EV/EBITDA

-539.7%
Upside

As of 2026-09-15, the EV/EBITDA ratio of Novacyt SA (ALNOV.PA) is -1.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALNOV.PA's latest enterprise value is 23.97 mil EUR. ALNOV.PA's TTM EBITDA according to its financial statements is -12.96 mil EUR. Dividing these 2 quantities gives us the above ALNOV.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.0x - 21.4x 14.2x
Forward P/E multiples 9.8x - 17.2x 12.8x
Fair Price (1.57) - (2.90) (2.22)
Upside -410.9% - -672.7% -539.7%
0.51 EUR
Stock Price
(2.22) EUR
Fair Price

ALNOV.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-09-14 -1.85
2026-09-11 -1.85
2026-09-10 -1.87
2026-09-09 -1.83
2026-09-08 -1.87
2026-09-07 -1.77
2026-09-04 -1.87
2026-09-03 -1.85
2026-09-02 -1.88
2026-09-01 -2.00
2026-08-31 -1.83
2026-08-28 -1.77
2026-08-27 -1.79
2026-08-26 -1.84
2026-08-25 -1.87
2026-08-24 -1.89
2026-08-21 -1.99
2026-08-20 -1.76
2026-08-19 -1.89
2026-08-18 -2.07
2026-08-17 -2.07
2026-08-14 -1.92
2026-08-13 -1.89
2026-08-12 -2.10
2026-08-11 -1.68
2026-08-10 -1.59
2026-08-07 -1.48
2026-08-06 -1.45
2026-08-05 -1.46
2026-08-04 -1.41
2026-08-03 -1.35
2026-07-31 -1.40
2026-07-30 -1.40
2026-07-29 -1.47
2026-07-28 -1.53
2026-07-27 -1.54
2026-07-24 -1.51
2026-07-23 -1.53
2026-07-22 -1.53
2026-07-21 -1.53
2026-07-20 -1.56
2026-07-17 -1.58
2026-07-16 -1.59
2026-07-15 -1.37
2026-07-14 -1.36
2026-07-13 -1.31
2026-07-10 -1.28
2026-07-09 -1.31
2026-07-08 -1.23
2026-07-07 -1.26